🔍 Key Findings
- Liposomal bupivacaine (LB) infiltration did not reduce the need for rescue analgesia compared with placebo in dogs undergoing TPLO.
- CMPS-SF pain scores were not significantly different between LB and placebo groups at any postoperative time point.
- % body weight distribution (%BWdist) to the operated limb did not differ significantly between treatment groups across all time points.
- No correlation was found between CMPS-SF scores and %BWdist, suggesting these metrics assess different aspects of postoperative pain.
- Postoperative carprofen administration was standardized, and LB did not provide additional detectable analgesic benefit.
- Three-layer infiltration technique (joint capsule, fascia, subcutis) was used consistently across all cases.
- Adverse events were minor and comparable between LB and placebo groups.
- Post hoc analysis suggested a much larger sample size (58–436 dogs) would be needed to detect significant differences in %BWdist.

